Skip to main content

Advertisement

SpringerLink
Log in

Benign prostatic hyperplasia is associated with increased 90-day medical complications but not peri-prosthetic joint infections following reverse shoulder arthroplasty

  • Original Article
  • Published:
European Journal of Orthopaedic Surgery & Traumatology Aims and scope Submit manuscript

Abstract

Introduction

Studies have shown male sex to be a predisposing factor for peri-prosthetic joint infections (PJIs). Symptomatic benign prostatic hyperplasia (BPH) has been suggested as an additional risk for PJI. This study aimed to assess the impact of BPH on (1) lengths of stay (LOS), (2) complications (medical and implant-related), (3) readmission rates, and (4) healthcare expenditures after reverse shoulder arthroplasty (RSA).

Methods

Utilizing a nationwide sample from the 2010–2020 PearlDiver insurance database, an analysis was performed retrospectively for all males who underwent primary RSA. Males with BPH (n = 2,184) represented the study group and were ratio-matched with men without a history of BPH (n = 10,832) in a 1:5 manner by medical comorbidities. T-tests compared LOS and healthcare expenditures. Multivariate logistic regression models were used to determine the effect of BPH on 90-day medical complications, 2-year implant complications, and readmissions. A p value less than 0.001 was statistically significant.

Results

In-hospital LOS (1.96 days vs. 1.99 days, p = 0.683) did not significantly differ between cohorts. Males with BPH had significantly greater occurrence and odds (34.3% vs. 21.2%, odds ratio (OR):1.84, p < 0.0001) of all 90-day medical complications, including urinary tract infections (9.3% vs. 3.1%, OR:3.23, p < 0.0001), pneumonias (6.0% vs. 3.9%, OR:1.61, p < 0.0001), and acute kidney injuries (7.7% vs. 5.0%, OR:1.60, p < 0.0001). Two-year implant-related complications were comparable between study and control groups (12.2% vs 10.9%, OR:1.14, p = 0.073), including PJIs (2.3% vs. 2.2%, OR:1.02, p = 0.874). Readmission rates (1.88% vs. 2.11%, p = 0.482) and average global 90-day reimbursements ($26,301 vs. $24,399), p = 0.535) were similar between men with and without BPH.

Discussion

Males with a history of BPH have greater rates of medical complications, including UTIs and acute kidney injuries, within 90 days following RSA. BPH does not appear to be a risk factor for 2-year implant-related complications including PJIs.

Level of Evidence

III.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Day JS, Lau E, Ong KL et al (2010) Prevalence and projections of total shoulder and elbow arthroplasty in the United States to 2015. J Shoulder Elb Surg 19:1115–1120. https://doi.org/10.1016/j.jse.2010.02.009

    Article  Google Scholar 

  2. Kim SH, Wise BL, Zhang Y, Szabo RM (2011) Increasing incidence of shoulder arthroplasty in the United States. J Bone Jt Surg - Ser A 93:2249–2254. https://doi.org/10.2106/JBJS.J.01994

    Article  Google Scholar 

  3. Sloan M, Premkumar A, Sheth NP (2018) Projected volume of primary total joint arthroplasty in the u.s., 2014 to 2030. J Bone Jt Surg - Am 100:1455–1460. https://doi.org/10.2106/JBJS.17.01617

    Article  Google Scholar 

  4. Wagner ER, Farley KX, Higgins I et al (2020) The incidence of shoulder arthroplasty: rise and future projections compared with hip and knee arthroplasty. J Shoulder Elb Surg 29:2601–2609. https://doi.org/10.1016/J.JSE.2020.03.049

    Article  Google Scholar 

  5. Farley KX, Wilson JM, Daly CA et al (2019) The incidence of shoulder arthroplasty: rise and future projections compared to hip and knee arthroplasty. JSES Open Access 3:244. https://doi.org/10.1016/J.JSES.2019.10.047

    Article  Google Scholar 

  6. Farley KX, Wilson JM, Kumar A et al (2021) Prevalence of shoulder arthroplasty in the United States and the increasing burden of revision shoulder arthroplasty. JBJS Open Access. https://doi.org/10.2106/JBJS.OA.20.00156

    Article  PubMed  PubMed Central  Google Scholar 

  7. Paxton ES, Green A, Krueger VS (2019) Periprosthetic infections of the shoulder: diagnosis and management. J Am Acad Orthop Surg 27:E935–E944. https://doi.org/10.5435/JAAOS-D-18-00232

    Article  PubMed  Google Scholar 

  8. Padegimas EM, Maltenfort M, Ramsey ML et al (2015) Periprosthetic shoulder infection in the United States: incidence and economic burden. J Shoulder Elb Surg 24:741–746. https://doi.org/10.1016/j.jse.2014.11.044

    Article  Google Scholar 

  9. Contreras ES, Frantz TL, Bishop JY, Cvetanovich GL (2020) Periprosthetic infection after reverse shoulder arthroplasty: a review. Curr Rev Musculoskelet Med 13:757–768. https://doi.org/10.1007/s12178-020-09670-8

    Article  PubMed  PubMed Central  Google Scholar 

  10. Cooper ME, Trivedi NN, Sivasundaram L et al (2019) Diagnosis and management of periprosthetic joint infection after shoulder arthroplasty. JBJS Rev. https://doi.org/10.2106/JBJS.RVW.18.00152

    Article  PubMed  Google Scholar 

  11. Garrigues GE, Zmistowski B, Cooper AM et al (2019) Proceedings from the 2018 International consensus meeting on orthopedic infections: the definition of periprosthetic shoulder infection. J Shoulder Elb Surg 28:S8–S12. https://doi.org/10.1016/J.JSE.2019.04.034

    Article  Google Scholar 

  12. Kunutsor SK, Whitehouse MR, Blom AW, Beswick AD (2016) Patient-related risk factors for periprosthetic joint infection after total joint arthroplasty: a systematic review and meta-analysis. PLoS ONE. https://doi.org/10.1371/JOURNAL.PONE.0150866

    Article  PubMed  PubMed Central  Google Scholar 

  13. Patel VV, Ernst SMC, Rangarajan R et al (2021) Validation of new shoulder periprosthetic joint infection criteria. J Shoulder Elb Surg 30:S71–S76. https://doi.org/10.1016/j.jse.2021.04.009

    Article  Google Scholar 

  14. Simha S, Shields EJW, Wiater JM (2018) Periprosthetic Infections of the Shoulder. JBJS Rev 6:e6. https://doi.org/10.2106/JBJS.RVW.17.00191

    Article  PubMed  Google Scholar 

  15. Wright-Chisem J, Apostolakos JM, Dines JS et al (2021) The impact of prior ipsilateral arthroscopy on infection rates after shoulder arthroplasty. J Shoulder Elb Surg 30:1596–1602. https://doi.org/10.1016/j.jse.2020.09.019

    Article  Google Scholar 

  16. Werner BC, Burrus MT, Begho I et al (2015) Early revision within 1 year after shoulder arthroplasty: patient factors and etiology. J Shoulder Elb Surg 24:e323–e330. https://doi.org/10.1016/j.jse.2015.05.035

    Article  Google Scholar 

  17. Cancienne JM, Brockmeier SF, Carr JC, Werner BC (2018) Implant removal and spacer placement for infected shoulder arthroplasty: risk factors for repeat procedures, spacer retention, and mortality. HSS J 14:228–232. https://doi.org/10.1007/s11420-017-9586-0

    Article  CAS  PubMed  Google Scholar 

  18. Cancienne JM, Brockmeier SF, Werner BC (2018) Association of perioperative glycemic control with deep postoperative infection after shoulder arthroplasty in patients with diabetes. J Am Acad Orthop Surg 26:e238–e245. https://doi.org/10.5435/JAAOS-D-16-00784

    Article  PubMed  Google Scholar 

  19. Werner BC, Cancienne JM, Burrus MT et al (2016) The timing of elective shoulder surgery after shoulder injection affects postoperative infection risk in Medicare patients. J Shoulder Elb Surg 25:390–397. https://doi.org/10.1016/j.jse.2015.08.039

    Article  Google Scholar 

  20. Werner BC, Burrus MT, Browne JA, Brockmeier SF (2015) Superobesity (body mass index >50 kg/m2) and complications after total shoulder arthroplasty: an incremental effect of increasing body mass index. J Shoulder Elb Surg 24:1868–1875. https://doi.org/10.1016/j.jse.2015.05.046

    Article  Google Scholar 

  21. Aibinder W, Schoch B, Parsons M et al (2021) Risk factors for complications and revision surgery after anatomic and reverse total shoulder arthroplasty. J Shoulder Elb Surg. https://doi.org/10.1016/j.jse.2021.04.029

    Article  Google Scholar 

  22. Okoroha KR, Muh S, Gabbard M et al (2019) Early outcomes of shoulder arthroplasty according to sex. JSES Open Access 3:43–47. https://doi.org/10.1016/J.JSES.2018.12.001

    Article  PubMed  PubMed Central  Google Scholar 

  23. Kapadia BH, Berg RA, Daley JA et al (2015) Periprosthetic joint infection. Lancet. https://doi.org/10.1016/S0140-6736(14)61798-0

    Article  PubMed  Google Scholar 

  24. Richards J, Inacio MCS, Beckett M et al (2014) Patient and procedure-specific risk factors for deep infection after primary shoulder arthroplasty. Clin Orthop Relat Res 472:2809–2815. https://doi.org/10.1007/s11999-014-3696-5

    Article  PubMed  PubMed Central  Google Scholar 

  25. Gubbels Bupp MR, Potluri T, Fink AL, Klein SL (2018) The confluence of sex hormones and aging on immunity. Front Immunol. https://doi.org/10.3389/FIMMU.2018.01269

    Article  PubMed  PubMed Central  Google Scholar 

  26. Klein SL, Flanagan KL (2016) Sex differences in immune responses. Nat Rev Immunol. 16:626–638. https://doi.org/10.1038/nri.2016.90

    Article  CAS  PubMed  Google Scholar 

  27. Moverman MA, Bruha MJ, Pagani NR et al (2021) Perioperative medical optimization of symptomatic benign prostatic hyperplasia is an economically justified infection prevention strategy in total joint arthroplasty. J Arthroplasty 36:2551–2557. https://doi.org/10.1016/j.arth.2021.02.059

    Article  PubMed  Google Scholar 

  28. Gu A, Agarwal A, Fassihi SC et al (2021) Does symptomatic benign prostatic hyperplasia increase the risk of periprosthetic joint infection after primary total joint arthroplasty? J Arthroplasty 36:897–904. https://doi.org/10.1016/J.ARTH.2020.09.017

    Article  PubMed  Google Scholar 

  29. Yazdi H, Restrepo C, Foltz C et al (2020) Symptomatic benign prostatic hyperplasia: a risk factor for periprosthetic joint infection in Male patients. J Bone Jt Surg - Am 102:543–549. https://doi.org/10.2106/JBJS.19.00865

    Article  Google Scholar 

  30. Wei JT, Calhoun E, Jacobsen SJ (2005) Urologic diseases in America project: Benign prostatic hyperplasia. J Urol 173:1256–1261. https://doi.org/10.1097/01.ju.0000155709.37840.fe

    Article  PubMed  Google Scholar 

  31. Premkumar A, Kolin DA, Farley KX et al (2021) Projected economic burden of periprosthetic joint infection of the hip and knee in the United States. J Arthroplasty 36:1484-1489.e3. https://doi.org/10.1016/j.arth.2020.12.005

    Article  PubMed  Google Scholar 

  32. Casp AJ, Montgomery SR, Cancienne JM et al (2020) Osteoporosis and implant-related complications after anatomic and reverse total shoulder arthroplasty. J Am Acad Orthop Surg 28:121–127. https://doi.org/10.5435/JAAOS-D-18-00537

    Article  PubMed  Google Scholar 

  33. Khazi ZM, Lu Y, Patel BH et al (2020) Risk factors for opioid use after total shoulder arthroplasty. J Shoulder Elb Surg 29:235–243. https://doi.org/10.1016/j.jse.2019.06.020

    Article  Google Scholar 

  34. Berglund DD, Rosas S, Kurowicki J et al (2018) Effect of opioid dependence or abuse on opioid utilization after shoulder arthroplasty. World J Orthop 9:105–111. https://doi.org/10.5312/wjo.v9.i8.105

    Article  PubMed  PubMed Central  Google Scholar 

  35. Casp AJ, Smith JM, Brockmeier SF, Werner BC (2020) Surgeon charges and reimbursements are declining compared with hospital payments for shoulder arthroplasty. J Shoulder Elb Surg 29:924–930. https://doi.org/10.1016/j.jse.2019.09.023

    Article  Google Scholar 

  36. Cancienne JM, Brockmeier SF, Gulotta LV et al (2017) Ambulatory total shoulder arthroplasty: a comprehensive analysis of current trends, complications, readmissions, and costs. J Bone Jt Surg - Am 99:629–637. https://doi.org/10.2106/JBJS.16.00287

    Article  Google Scholar 

  37. Elixhauser A, Steiner C, Harris DR, Coffey RM (1998) Comorbidity measures for use with administrative data. Med Care 36:8–27. https://doi.org/10.1097/00005650-199801000-00004

    Article  CAS  PubMed  Google Scholar 

  38. Parsons JK (2007) Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems. J Urol 178:395–401. https://doi.org/10.1016/j.juro.2007.03.103

    Article  PubMed  Google Scholar 

  39. Gordon AM, Horn AR, Lam AW et al (2022) The association of benign prostatic hyperplasia on postoperative complications and periprosthetic joint infections following total shoulder arthroplasty. Shoulder Elbow. https://doi.org/10.1177/17585732221081012

    Article  PubMed  Google Scholar 

  40. Blanchard NP, Browne JA, Werner BC (2022) The timing of preoperative urinary tract infection influences the risk of prosthetic joint infection following primary total hip and knee arthroplasty. J Arthroplasty. https://doi.org/10.1016/J.ARTH.2022.05.034

    Article  PubMed  Google Scholar 

  41. Schoch BS, King JJ, Wright TW et al (2022) Patient age at time of reverse shoulder arthroplasty remains stable over time: a 7.5-year trend evaluation. Eur J Orthop Surg Traumatol. https://doi.org/10.1007/S00590-022-03227-W

    Article  PubMed  Google Scholar 

  42. Kowalik U, Plante MK (2016) Urinary Retention in Surgical Patients. Surg Clin North Am 96:453–467. https://doi.org/10.1016/J.SUC.2016.02.004

    Article  PubMed  Google Scholar 

  43. Ortmaier R, Resch H, Hitzl W et al (2014) Treatment strategies for infection after reverse shoulder arthroplasty. Eur J Orthop Surg Traumatol 24:723–731. https://doi.org/10.1007/S00590-013-1251-9

    Article  PubMed  Google Scholar 

  44. Guo L-L, Cheng T-P, Feng L-X et al (2022) Incidence and risk factors for deep infection after primary shoulder arthroplasty: a meta-analysis. Eur Rev Med Pharmacol Sci 26:4606–4613. https://doi.org/10.26355/EURREV_202207_29182

    Article  PubMed  Google Scholar 

  45. Wickman JR, Goltz DE, Levin JM et al (2021) Early aseptic reoperation after shoulder arthroplasty increases risk of subsequent prosthetic joint infection. JSES Int. https://doi.org/10.1016/J.JSEINT.2021.06.002

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

The authors received no funding for this study and report.

Author information

Authors and Affiliations

  1. Department of Orthopaedic Surgery and Rehabilitation, Maimonides Medical Center, 927 49th Street, Brooklyn, NY, 11219, USA

    Adam M. Gordon, Keith B. Diamond, Asad M. Ashraf, Matthew L. Magruder, Ramin Sadeghpour & Jack Choueka

Authors
  1. Adam M. Gordon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Keith B. Diamond
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Asad M. Ashraf
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Matthew L. Magruder
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ramin Sadeghpour
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jack Choueka
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Adam M. Gordon.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Ethical approval

This study was determined to be exempt from the Institutional Review Board (IRB) of Maimonides Medical Center.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 14 KB)

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gordon, A.M., Diamond, K.B., Ashraf, A.M. et al. Benign prostatic hyperplasia is associated with increased 90-day medical complications but not peri-prosthetic joint infections following reverse shoulder arthroplasty. Eur J Orthop Surg Traumatol 33, 1773–1779 (2023). https://doi.org/10.1007/s00590-022-03344-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00590-022-03344-6

Keywords

Search

Navigation